New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
10:29 EDTAUXLAuxilium generic Testim strategy defended at UBS
UBS believes Auxilium shares are lower as investors assume Upsher’s generic version of Testim could be approved as an AB-rated generic, but the firm noted that is not yet the case. UBS thinks Auxilium shares will recover as investors recognize that the generic strategy should maximize Testim sales over the medium term and maintains its Buy rating and $31 price target on the stock.
News For AUXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
06:13 EDTAUXLAuxilium reports Q3 EPS 27c, consensus 10c
Subscribe for More Information
October 21, 2014
08:13 EDTAUXLBioSpecifics announces FDA approval of sBLA for XIAFLEX
Subscribe for More Information
October 20, 2014
17:33 EDTAUXLAuxilium announces XIAFLEX approved for treatment of up to two DC joints
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use